Revolutionizing Prescription Drug Pricing and Personal Priorities

This chapter delves into the launch of Cost Plus Drugs, a venture targeting the abolition of middlemen in the prescription drug industry to offer consumers lower prices. It also touches on the speaker's views on healthcare reform versus political ambitions, highlighting a commitment to transparency and real costs.